Pharma Q1FY27 preview: Domestic strength to offset muted US growth
The Indian pharmaceutical market grew 12% year-on-year in April-May 2026, well above the three-year quarterly average of 9%. Growth was led by oncology, anti-diabetic therapies (driven by GLP-1 drugs), cardiac, urology, vitamins, minerals and nutrients (VMN), and pain therapies, all of which expanded more than 12%.
Post Comment